CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenues:
Net product sales	$ 18,768	$ 5,241	$ 61,041	$ 8,176
Collaborative agreement	135	895	363	5,689
Royalties		866		5,961
Total revenues	18,903	7,002	61,404	19,826
Cost of product sales	4,037	1,940	17,066	3,724
Operating expenses:
Research and development	5,776	5,254	21,458	31,304
Selling, general and administrative	30,367	35,103	133,925	76,645
Pre-existing settlement gain		(80,229)		(80,229)
Amortization expense of intangible assets	1,985	1,408	5,953	1,408
Change in fair value of contingent consideration	(500)	1,000	1,600	1,000
Total operating expenses	37,628	(37,464)	162,936	30,128
Loss from operations	(22,762)	42,526	(118,598)	(14,026)
Other income (expense):
Interest income	180	239	444	525
Interest expense	(794)	(1,988)	(2,830)	(5,878)
Change in fair value of financial instruments	(628)	6,100	(22,668)	17,700
Gain on extinguishment of debt			12,316
Foreign currency gain (loss), net	3,175	786	10,902	1,764
Total other income (expense)	1,933	5,137	(1,836)	14,111
Net income (loss) - basic	(20,829)	47,663	(120,434)	85
Net income (loss) - diluted	$ (20,829)	$ 40,963	$ (120,434)	$ 85
Basic net income (loss) per share	$ (1.35)	$ 3.27	$ (7.94)	$ 0.01
Diluted net income (loss) per share	$ (1.35)	$ 1.12	$ (7.94)	$ 0.01
Basic shares used in computing net income (loss) per share	15,440	14,587	15,164	14,570
Diluted shares used in computing net income (loss) per share	15,440	36,615	15,164	14,570